Interview a patient with a chronic pulmonary health condition who is on at least two medications.

In a 1,350-1,600-word paper, discuss the following:

1. Obtain a complete health history.
2. Obtain a complete medication history, including prescription and over-the-counter drugs or supplements.
3. Analyze the client’s current knowledge level of medications and compliance with the prescribed dosing and administration.
4. For each medication, identify the pharmacokinetics, pharmacodynamics, dose, route of administration, side effects, adverse reactions, any drug interactions, potential safety issues, and the impact on the client’s health status.
5. Formulate possible interventions related to lack of drug efficacy, lack of client knowledge, or client compliance issues as identified during the interview.

Prepare this assignment according to the APA guidelines found in the APA Style Guide, located in the Student Success Center. An abstract is not required.  # references

Chronic respiratory diseases (CRDs) are diseases of the airways and other structures of the lung. Some of the most common are chronic obstructive pulmonary disease (COPD), asthma, occupational lung diseases and pulmonary hypertension. In addition to tobacco smoke, other risk factors include air pollution, occupational chemicals and dusts, and frequent lower respiratory infections during childhood. CRDs are not curable, however, various forms of treatment that help dilate major air passages and improve shortness of breath can help control symptoms and increase the quality of life for people with the disease. The WHO Global Alliance against CRDs (GARD) has a vision of a world in which all people breathe freely, and focuses in particular on the needs of people with CRDs in low-income and middle-income countries.

The aim of the WHO Chronic Respiratory Diseases Programme is to support Member States in their efforts to reduce the toll of morbidity, disability and premature mortality related to chronic respiratory diseases, and specifically, asthma and chronic obstructive pulmonary disease.